Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04LIR
|
||||
| Former ID |
DIB007235
|
||||
| Drug Name |
PD-159913
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cerebrovascular ischaemia [ICD9: 434.91; ICD10:I61-I63] | Terminated | [1] | ||
| Company |
Pfizer Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H20NO5P
|
||||
| Canonical SMILES |
N[C@@H](Cc1cc(CP(=O)(O)O)cc(c1)c2ccc3ccccc3c2)C(=O)O
|
||||
| InChI |
1S/C20H20NO5P/c21-19(20(22)23)10-13-7-14(12-27(24,25)26)9-18(8-13)17-6-5-15-3-1-2-4-16(15)11-17/h1-9,11,19H,10,12,21H2,(H,22,23)(H2,24,25,26)/t19-/m0/s1
|
||||
| InChIKey |
GOPXMKDIVJBBQF-IBGZPJMESA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008061) | ||||
| REF 2 | WO patent application no. 2009,0164,86, Use of nmda receptor antagonists for treatment of urologic tumors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.